Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AMIKIN

AMIKACIN SULFATE

Standard Dose
EQ 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AMIKIN is listed in Drugs@FDA under application 050495 (NDA).

Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor APOTHECON Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview AMIKIN is listed in Drugs@FDA under application 050495 (NDA). Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor APOTHECON Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
AMIKIN (AMIKACIN SULFATE) | Drug Monograph | MedicHelpline